APP |
Amyloid-Precursor Protein |
AQP4 |
Aquaporin-4 Protein |
BBB |
Blood-Brain Barrier |
CDMS |
Clinically Defined MS |
CHI3L1 |
Chitinase-3-Like-1 Precursor |
CIS |
Clinically Isolated Syndrome |
CSF |
Cerebro Spinal Fluid |
DMT |
Disease-Modifying Therapies |
DTI |
Diffusion Tensor Imaging |
DWI |
Diffusion Weighted Imaging |
EBNA |
Epstein-Barr Nuclear Antigen |
FLAIR |
FLuid Attenuated Inversion Recovery Sequence |
KFLC |
Kappa Free Light Chain |
LFLC |
Lambda Free Light Chain |
MBP |
Myelin Basic Protein |
MOG |
Myelin Oligodendrocyte Glycoprotein |
MS |
Multiple Sclerosis |
MRI |
Magnetic Resonance Imaging |
MRS |
Magnetic Resonance Spectroscopy |
MTI |
Magnetization Transfer Imaging |
MTR |
Magnetization Transfer Ratio |
NAA |
N-Acetyl-Aspartate |
NAWM |
Normal-Appearing White Matter |
NF |
Neurofilaments |
GFAP |
Glial Fibrillary Acidic Protein |
NMOSD |
Neuromyelitis Optica Spectrum Disorders |
OCB |
Oligoclonal Bands |
OCGB |
IgG-Type Oligoclonal Bands |
OCMB |
IgM-Type Oligoclonal Bands |
OCT |
Optical Coherence Tomography |
PD-SE |
Proton Density-Weighted Spin-Echo Imaging |
PET |
Positron Emission Tomography |
PPMS |
Primary Progressive MS |
RIS |
Radiologically Isolated Syndrome |
RNFL |
Retinal Nerve Fiber Layer |
RRMS |
Relapsing Remitting MS |
SPMS |
Secondary Progressive MS |
S-100B |
S100 Calcium-Binding Protein B |
VCA |
Viral Capsid Antigen |